SYS6023

SYS6023 · CSPC Megalith Biopharmaceutical Co.,Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SYS6023, covering 2025-08-08 to 2025-08-08. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of SYS6023 in Patients With Advanced Solid Tumors [Phase 1]